First Time Loading...

Exagen Inc
NASDAQ:XGN

Watchlist Manager
Exagen Inc Logo
Exagen Inc
NASDAQ:XGN
Watchlist
Price: 1.91 USD 8.52%
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

56.9m
-7%
Assets
Growth Rates:
1 Year
-34%
3 Years
-27%
5 Years
-
7 Years
-
10 Years
+245%
34.3m
+2%
Liabilities
Growth Rates:
1 Year
-22%
3 Years
-6%
5 Years
-
7 Years
-
10 Years
+114%
22.7m
-17%
Equity
Growth Rates:
1 Year
-47%
3 Years
-46%
5 Years
-
7 Years
-
10 Years
+4 439%

Balance Sheet Decomposition
Exagen Inc

56.9m
Assets
34.3m
Liabilities
56.9m
Assets
34.3m
Liabilities
Current Assets 47.8m
Cash & Short-Term Investments 36.5m
Receivables 6.6m
Other Current Assets 4.8m
Non-Current Assets 9.1m
PP&E 8.5m
Other Non-Current Assets 616k
Current Liabilities 11.9m
Accounts Payable 3.1m
Accrued Liabilities 7.7m
Other Current Liabilities 1.1m
Non-Current Liabilities 22.3m
Long-Term Debt 19.6m
Other Non-Current Liabilities 2.8m

Balance Sheet
Exagen Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2012 Dec-2013 Dec-2014 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
3
8
5
11
13
72
57
99
62
36
Cash Equivalents
3
8
5
11
13
72
57
99
62
36
Total Receivables
0
0
0
1
6
6
9
10
6
7
Accounts Receivables
0
0
0
1
6
6
9
10
6
7
Other Receivables
0
0
0
0
0
0
0
0
0
0
Other Current Assets
1
0
1
1
2
4
4
4
4
5
Total Current Assets
4
8
5
13
21
81
71
113
73
48
PP&E Net
1
1
2
1
2
1
2
5
13
8
PP&E Gross
1
1
2
0
0
0
0
5
13
8
Accumulated Depreciation
1
1
2
0
0
0
0
4
5
6
Intangible Assets
1
1
1
0
0
0
0
0
0
0
Goodwill
6
6
6
6
6
6
6
6
0
0
Other Long-Term Assets
0
1
4
0
1
0
0
0
1
1
Other Assets
6
6
6
6
6
6
6
6
0
0
Total Assets
11
N/A
17
+46%
17
+4%
20
+19%
29
+42%
88
+206%
78
-11%
123
+57%
86
-30%
57
-34%
Liabilities
Accounts Payable
0
0
2
2
1
2
3
3
3
3
Accrued Liabilities
0
1
3
3
4
4
5
6
5
8
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
9
19
0
0
0
0
1
1
1
Other Current Liabilities
0
0
3
0
4
0
0
0
0
0
Total Current Liabilities
2
11
26
5
9
6
9
9
10
12
Long-Term Debt
1
0
0
19
25
26
27
28
30
20
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Other Liabilities
3
5
5
1
2
1
1
1
5
3
Total Liabilities
6
N/A
16
+150%
31
+95%
25
-20%
36
+42%
33
-8%
37
+12%
39
+5%
44
+14%
34
-22%
Equity
Common Stock
10
23
25
92
105
0
0
0
0
0
Retained Earnings
61
74
89
148
153
165
181
208
256
279
Additional Paid In Capital
56
52
51
51
41
220
223
293
298
302
Total Equity
5
N/A
1
-90%
14
N/A
5
+67%
7
-46%
56
N/A
42
-25%
85
+103%
43
-50%
23
-47%
Total Liabilities & Equity
11
N/A
17
+46%
17
+4%
20
+19%
29
+42%
88
+206%
78
-11%
123
+57%
86
-30%
57
-34%
Shares Outstanding
Common Shares Outstanding
12
12
12
12
12
13
13
16
17
17

See Also

Summary
XGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
XGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XGN stock valuation using valuation multiples.
Wall Street Estimates
XGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.